Skip to main content

Medical Subject Headings

Search from vocabulary

Content language

Concept information

Nucleic Acids, Nucleotides, and Nucleosides > Nucleosides > Deoxyribonucleosides > Pentostatin
Carbohydrates > Glycosides > Nucleosides > Deoxyribonucleosides > Pentostatin
... > Nucleic Acids, Nucleotides, and Nucleosides > Nucleosides > Ribonucleosides > Formycins > Coformycin > Pentostatin
... > Carbohydrates > Glycosides > Nucleosides > Ribonucleosides > Formycins > Coformycin > Pentostatin
... > Heterocyclic Compounds > Heterocyclic Compounds, 1-Ring > Pyrimidines > Pyrimidine Nucleosides > Formycins > Coformycin > Pentostatin
... > Nucleic Acids, Nucleotides, and Nucleosides > Nucleosides > Pyrimidine Nucleosides > Formycins > Coformycin > Pentostatin
... > Carbohydrates > Glycosides > Nucleosides > Pyrimidine Nucleosides > Formycins > Coformycin > Pentostatin

Preferred term

Pentostatin  

Type

  • Topical Descriptor

Broader concept

Entry terms

  • CI 825
  • CI-825
  • CI825
  • Co-Vidarabine
  • Deoxycoformycin
  • Nipent
  • NSC 218321
  • NSC-218321
  • NSC218321

Scope note

  • A potent inhibitor of ADENOSINE DEAMINASE. The drug induces APOPTOSIS of LYMPHOCYTES, and is used in the treatment of many lymphoproliferative malignancies, particularly HAIRY CELL LEUKEMIA. It is also synergistic with some other antineoplastic agents and has immunosuppressive activity.

History note

  • 1997 (1990); for CO-VIDARABINE use PENTOSTATIN 1982-1997

In other languages

URI

http://www.yso.fi/onto/mesh/D015649

Download this concept:

RDF/XML TURTLE JSON-LD Created 5/25/89, last modified 7/1/19